These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 14504973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [Abstract] [Full Text] [Related]

  • 3. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R, Weinstock-Guttman B, Zorzon M, Uxa L, Serafin M, Bosco A, Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B, Ramanathan M.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):123-30. PubMed ID: 19232441
    [Abstract] [Full Text] [Related]

  • 4. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E, Dwyer MG, Weinstock-Guttman B, Lema J, Bastianello S, Bergamaschi R, Cosi V, Benedict RH, Munschauer FE, Zivadinov R.
    Neuroimage; 2007 Jul 01; 36(3):746-54. PubMed ID: 17498974
    [Abstract] [Full Text] [Related]

  • 5. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
    Fernández O, Fernández V, Alonso A, Caballero A, Luque G, Bravo M, León A, Mayorga C, Leyva L, de Ramón E.
    J Neurol; 2004 Apr 01; 251(4):440-4. PubMed ID: 15083289
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients.
    Zivadinov R, Nasuelli D, Tommasi MA, Serafin M, Bratina A, Ukmar M, Pirko I, Johnson AJ, Furlan C, Pozzi-Mucelli RS, Monti-Bragadin L, Grop A, Zambon M, Antonello RM, Cazzato G, Zorzon M.
    Neurol Res; 2006 Apr 01; 28(3):262-9. PubMed ID: 16687051
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR.
    Hum Mol Genet; 2006 Sep 15; 15(18):2813-24. PubMed ID: 16905561
    [Abstract] [Full Text] [Related]

  • 13. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR, Reiche EM, Brum Souza DG, Frota Comini ER, Bobroff F, Morimoto HK, Ehara Watanabe MA, Carvalho De Oliveira J, Matsuo T, Lopes J, Donadi EA.
    Int J Mol Med; 2007 Sep 15; 20(3):337-44. PubMed ID: 17671738
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin.
    Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C, Savi M, Buzio C, Neri TM.
    Arthritis Rheum; 2006 Feb 15; 55(1):126-30. PubMed ID: 16463424
    [Abstract] [Full Text] [Related]

  • 16. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group.
    Mult Scler; 2009 Jul 15; 15(7):779-88. PubMed ID: 19542262
    [Abstract] [Full Text] [Related]

  • 17. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
    Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M.
    J Neurol Sci; 2004 Aug 30; 223(2):185-93. PubMed ID: 15337621
    [Abstract] [Full Text] [Related]

  • 18. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
    Baronica KB, Mlinac K, Ozretić D, Vladić A, Bognar SK.
    Coll Antropol; 2011 Jan 30; 35 Suppl 1():11-6. PubMed ID: 21648305
    [Abstract] [Full Text] [Related]

  • 19. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L, Veggiotti P, Comi G, Filippi M.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.